Ruby C. Chou

1.0k total citations
28 papers, 846 citations indexed

About

Ruby C. Chou is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Ruby C. Chou has authored 28 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Pharmacology and 7 papers in Oncology. Recurrent topics in Ruby C. Chou's work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Retinoids in leukemia and cellular processes (7 papers). Ruby C. Chou is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (7 papers) and Retinoids in leukemia and cellular processes (7 papers). Ruby C. Chou collaborates with scholars based in Switzerland, United States and France. Ruby C. Chou's co-authors include Sylvie Dupin, Ph. Coassolo, Christophe Schmitt, D Jaeck, Jeroen Buters, G Lévy, G. Ubeaud, Thierry Lavé, Anne Schmitt‐Hoffmann and Roger D. Brandt and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, International Journal of Pharmaceutics and Biochemical Pharmacology.

In The Last Decade

Ruby C. Chou

28 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruby C. Chou Switzerland	17	395	230	224	152	80	28	846
Philippe Coassolo Switzerland	20	577 1.5×	271 1.2×	350 1.6×	184 1.2×	83 1.0×	45	1.4k
Mitsukazu Kitada Japan	18	426 1.1×	259 1.1×	276 1.2×	36 0.2×	115 1.4×	61	939
Hilde Bohets Belgium	11	311 0.8×	209 0.9×	254 1.1×	69 0.5×	72 0.9×	18	769
Xavier Boulenc France	15	336 0.9×	198 0.9×	303 1.4×	59 0.4×	94 1.2×	19	814
Takafumi Iwatsubo Japan	18	688 1.7×	264 1.1×	524 2.3×	153 1.0×	140 1.8×	33	1.2k
Hans Postlind Sweden	13	805 2.0×	393 1.7×	457 2.0×	67 0.4×	96 1.2×	19	1.4k
James G. Baxter United States	8	552 1.4×	441 1.9×	385 1.7×	201 1.3×	104 1.3×	10	1.3k
Masahiro Iwaki Japan	18	268 0.7×	271 1.2×	304 1.4×	20 0.1×	91 1.1×	71	924
Philip Wastall United States	6	525 1.3×	350 1.5×	349 1.6×	196 1.3×	84 1.1×	8	1.2k
Marina Tinel France	25	795 2.0×	401 1.7×	378 1.7×	77 0.5×	114 1.4×	47	1.5k

Countries citing papers authored by Ruby C. Chou

Since Specialization

Citations

This map shows the geographic impact of Ruby C. Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby C. Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby C. Chou more than expected).

Fields of papers citing papers by Ruby C. Chou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby C. Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby C. Chou. The network helps show where Ruby C. Chou may publish in the future.

Co-authorship network of co-authors of Ruby C. Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Ruby C. Chou. A scholar is included among the top collaborators of Ruby C. Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruby C. Chou. Ruby C. Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chou, Ruby C., et al.. (1998). Pharmacokinetics of acitretin and etretinate. Journal of the American Academy of Dermatology. 39(2). S25–S33. 49 indexed citations

Chou, Ruby C., et al.. (1998). Pharmacokinetics of oral isotretinoin. Journal of the American Academy of Dermatology. 39(2). S8–S12. 38 indexed citations

Dupin, Sylvie, et al.. (1997). Integration of in Vitro Data into Allometric Scaling to Predict Hepatic Metabolic Clearance in Man: Application to 10 Extensively Metabolized Drugs. Journal of Pharmaceutical Sciences. 86(5). 584–590. 141 indexed citations

Dupin, Sylvie, Christophe Schmitt, G. Ubeaud, et al.. (1997). The Use of Human Hepatocytes to Select Compounds Based on Their Expected Hepatic Extraction Ratios in Humans. Pharmaceutical Research. 14(2). 152–155. 88 indexed citations

Dupin, Sylvie, et al.. (1996). Interspecies scaling of tolcapone, a new inhibitor of catechol-O-methyltransferase (COMT). Use ofin vitrodata from hepatocytes to predict metabolic clearance in animals and humans. Xenobiotica. 26(8). 839–851. 34 indexed citations

Levet‐Trafit, Bernard, et al.. (1996). Estimation of oral drug absorption in man based on intestine permeability in rats. Life Sciences. 58(24). PL359–PL363. 33 indexed citations

Lavé, Thierry, Philippe Coassolo, G. Ubeaud, et al.. (1996). Interspecies Scaling of Bosentan, A New Endothelin Receptor Antagonist and Integration of in Vitro Data into Allometric Scaling. Pharmaceutical Research. 13(1). 97–101. 38 indexed citations

Richter, W., et al.. (1996). Distribution of remikiren, a potent orally active inhibitor of human renin, in laboratory animals. Xenobiotica. 26(3). 243–254. 18 indexed citations

Coassolo, Ph., et al.. (1996). Pharmacokinetics of remikiren, a potent orally active inhibitor of human renin, in rat, dog and primates. Xenobiotica. 26(3). 333–345. 9 indexed citations

10.

Schmitt‐Hoffmann, Anne, et al.. (1995). Mechanistic studies on the ethyl-esterification of acitretin by human liver preparations in vitro. Life Sciences. 57(26). PL407–PL412. 8 indexed citations

11.

Lavé, Thierry, Anne Schmitt‐Hoffmann, Philippe Coassolo, et al.. (1995). A new extrapolation method from animals to man: Application to a metabolized compound, mofarotene. Life Sciences. 56(26). 473–478. 34 indexed citations

12.

Lavé, Thierry, et al.. (1995). Interspecies Scaling of Interferon Disposition and Comparison of Allometric Scaling with Concentration-Time Transformations. Journal of Pharmaceutical Sciences. 84(11). 1285–1290. 34 indexed citations

13.

Buters, Jeroen, et al.. (1993). A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man. Biochemical Pharmacology. 46(9). 1577–1584. 94 indexed citations

14.

Chou, Ruby C., et al.. (1992). A potentially new metabolic pathway: ethyl esterification of acitretin. Xenobiotica. 22(8). 993–1002. 18 indexed citations

15.

Chou, Ruby C., et al.. (1991). A newly discovered xenobiotic metabolic pathway: Ethyl ester formation. Life Sciences. 49(21). PL169–PL172. 19 indexed citations

16.

Chou, Ruby C., Iqbal Ramzan, & Gerhard Levy. (1984). Effect of pregnancy or renal dysfunction on differences in plasma protein binding of phenytoin in peripheral blood and blood exiting the liver of rats. International Journal of Pharmaceutics. 18(1-2). 217–221. 1 indexed citations

17.

Chou, Ruby C. & G Lévy. (1984). Effect of pregnancy on the pharmacokinetics of phenytoin in rats.. Journal of Pharmacology and Experimental Therapeutics. 229(2). 351–358. 12 indexed citations

18.

Chou, Ruby C., et al.. (1984). Determination of bupivacaine in human plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 311(1). 218–222. 31 indexed citations

19.

Chou, Ruby C., et al.. (1983). Changes in Plasma Protein Binding of Drugs after Blood Collection from Pregnant Women. Journal of Pharmaceutical Sciences. 72(6). 716–718. 4 indexed citations

20.

Chou, Ruby C., et al.. (1983). Hepatic Extraction of Free Fatty Acids in Pregnant and Nonpregnant Female Rats. Journal of Pharmaceutical Sciences. 72(10). 1230–1232. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact